Replies to post #2293 on Aleafia Health Inc (ALEAF)

[FUNMAN]

Kin Slips is going to be a big money winning homerun product for Aleafia. Especially with the industry low cost per gram.

Other than the social pleasure from smoking a joint, Kin Slips discreetly gets the exact job done that a "user" aims for.

Kin Slips is already a hit in the USA. Aleafia has the Canadian and international distribution rights. 

This is one of those added-value products that are going to be so important to building business from other SKUs beyond flower.

Thanks for posting 'Tenseevol'.


Aleafia Health Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

TORONTO, November 24, 2020 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of Kin Slips®, its rapid onset cannabis-infused sublingual strip portfolio, in the medical and adult-use markets. The innovative, award-winning format further strengthens Aleafia Health’s expansion of differentiated cannabis health and wellness products.


“The launch of Kin Slips in Canada represents a major milestone for Aleafia Health. Only six months after the licensing of our Paris Facility, we’ve brought one of Canada’s most innovative cannabis product formats to market,” said Aleafia Health CEO Geoffrey Benic. “Our team’s dedication has allowed us to deliver a product that stays true to the original vision of one of California’s most recognized cannabis brands.”


“The team at Kin Slips has spent years building, improving and perfecting this product so that it truly resonates with patients and consumers,” said Kin Slips chief product officer and co-founder Joshua Kirby. “To see it enter a new country with a partner in Aleafia Health that shares our values is incredibly gratifying.”


Kin Slips® highlights include:

• Rapid Onset: Kin Slips offers a fast onset time relative to other non-combustible cannabis products. Placed under the tongue, the active ingredients enter the bloodstream through the sublingual gland, delivering a typical onset time of 10 to 15 minutes (though individual experience may vary). In contrast, edibles enter the bloodstream through the digestive tract and stomach lining, which results in a slower onset time.


• Discreet, Novel Form Factor: Roughly the size of a postage stamp, Kin Slips offers consumers and patients a discreet experience. It is also highly accessible for patients with impaired motor functions who face challenges with other formats.


• Custom Terpene Profiles: Each Kin Slip SKU features a custom blend of botanically sourced terpenes.


• Natural Peppermint Flavour: Kin Slips are formulated with peppermint oil to deliver a fresh minty sensation. They are also vegan and contain only natural ingredients.


The new product line features three profiles and a total of five SKUs. They will be sold to medical patients as Emblem Kin Slips and in the adult-use market as Kin Slips by Symbl.

• Float On: Crafted with a blend of cannabinoids and terpenes commonly found in indica strains, Float On features two SKUs of 10 mg and five mg of THC per slip.


• Cloud Buster: Crafted with a blend of cannabinoids and terpenes commonly found in sativa strains, Cloud Buster features two SKUs of 10 mg and five mg of THC per slip.


• Park Life: Crafted with a blend of cannabinoids and terpenes commonly found in CBD strains, Park Life contains 10 mg of CBD per slip.


For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[e-mail]
LEARN MORE:www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.